Max Z.

Director at Cantabio Pharmaceuticals

Max Z. has extensive work experience in various roles and industries. Max currently serves as the Head Advisor at the Cambridge University Longevity Society since October 2022. Prior to this, they worked as a Domain Expert at Carbon13 starting in 2021. In 2020, Max Z. was the Founding President and Advisor at the Darwin Entrepreneurs Club.

From 2015 onwards, Max Z. held multiple positions at Cantabio Pharmaceuticals, Inc., including Director, Chief Business Development Officer, and Head of Computer-Aided Drug Design and Business Development. Max was responsible for driving the company's growth and development.

Before joining Cantabio Pharmaceuticals, Inc., Max Z. worked at Gardedam Therapeutics Inc. as the Director of Business Development (Asia) and Senior Research Scientist. Max also served as the Director and Technology Officer at Vitargent Biotechnologies Limited from 2013 to 2015.

Overall, Max Z. has demonstrated expertise in various domains and has made significant contributions throughout their career.

Max Z. completed their education in chronological order, starting with a Doctor of Philosophy - PhD in Computational Physics and Chemistry from the University of Cambridge. This degree was earned between 2008 and 2012. Following this, Max pursued an Executive MBA from the same institution, which they are expected to complete in 2022. The specific field of study for their MBA is not provided.

Links

Previous companies

Cantabio Pharmaceuticals logo

Timeline

  • Director

    January, 2018 - present

  • Chief Business Development Officer

    January, 2019

  • Head of Computer-Aided Drug Design and Business Development

    January, 2015